Skip to main content

PharmaCyte Biotech, Inc.

PMCB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001157075

No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in PharmaCyte Biotech, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
−2 vs. Q2 2022
Shares held
4.98M
+1.06M (+27.1%) vs. Q2 2022
Total value
$12.0M
+$3.17M (+36.0%) vs. Q2 2022
New holders
2
9 more added
Sold out
4
10 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 33 institutions
Q1 2021: 5 institutionsQ2 2021: 5 institutionsQ3 2021: 24 institutionsQ4 2021: 30 institutionsQ1 2022: 28 institutionsQ2 2022: 35 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 33 institutionsQ2 2023: 32 institutionsQ3 2023: 34 institutionsQ4 2023: 36 institutionsQ1 2024: 33 institutionsQ2 2024: 32 institutionsQ3 2024: 29 institutionsQ4 2024: 23 institutionsQ1 2025: 26 institutionsQ2 2025: 25 institutionsQ3 2025: 25 institutionsQ4 2025: 30 institutionsQ1 2026: 36 institutionsQ2 2026: 32 institutions
Value heldQ3 2022: $12.0M
Q1 2021: $8.68KQ2 2021: $5.43KQ3 2021: $4.42MQ4 2021: $8.68MQ1 2022: $8.83MQ2 2022: $8.79MQ3 2022: $12.0MQ4 2022: $9.93MQ1 2023: $10.2MQ2 2023: $3.47MQ3 2023: $2.40MQ4 2023: $2.35MQ1 2024: $2.32MQ2 2024: $2.02MQ3 2024: $1.58MQ4 2024: $934.3KQ1 2025: $709.9KQ2 2025: $632.1KQ3 2025: $419.9KQ4 2025: $712.0KQ1 2026: $643.2KQ2 2026: $586.2K
Institutions holding PMCB and their total value by quarter
QuarterHoldersValue
Q2 202632$586.2K
Q1 202636$643.2K
Q4 202530$712.0K
Q3 202525$419.9K
Q2 202525$632.1K
Q1 202526$709.9K
Q4 202423$934.3K
Q3 202429$1.58M
Q2 202432$2.02M
Q1 202433$2.32M
Q4 202336$2.35M
Q3 202334$2.40M
Q2 202332$3.47M
Q1 202333$10.2M
Q4 202234$9.93M
Q3 202233$12.0M
Q2 202235$8.79M
Q1 202228$8.83M
Q4 202130$8.68M
Q3 202124$4.42M
Q2 20215$5.43K
Q1 20215$8.68K

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q2 2022.

Institutions holding PMCB in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Ayrton Capital LLC1,033,130$2.48M4.35%+880,000+574.7%Added
Shay Capital LLC1,015,666$2.44M1.22%+32,968+3.4%Added
Vanguard Group Inc643,174$1.54M0.00%+800+0.1%Added
K2 Principal Fund, L.P.611,163$1.47M0.35%+520,068+570.9%Added
Sabby Management, LLC567,600$1.36M2.95%−493,811−46.5%Reduced
Equitec Proprietary Markets, LLC330,694$794.0K0.35%−12,300−3.6%Reduced
Csenge Advisory Group200,104$480.0K0.04%+200,104New
Geode Capital Management, LLC175,607$421.0K0.00%00.0%Unchanged
Group One Trading, L.P.75,052$180.0K0.01%+6,011+8.7%Added
Simplex Trading, LLC65,420$157.0K0.01%+10,493+19.1%Added
State Street Corp62,600$150.0K0.00%00.0%Unchanged
Price T Rowe Associates Inc47,000$113.0K0.00%−15,000−24.2%Reduced
Davy Global Fund Management Ltd38,771$93.0K0.02%+38,771New
Northern Trust Corp37,630$90.0K0.00%00.0%Unchanged
Schonfeld Strategic Advisors LLC24,800$60.0K0.00%−1,400−5.3%Reduced
Millennium Management LLC25,018$60.0K0.00%+7,499+42.8%Added
Susquehanna International Group, LLP16,624$40.0K0.00%−61,985−78.9%Reduced
BlackRock Inc.11,148$27.0K0.00%+2,267+25.5%Added
Advisor Group Holdings, Inc.1,758$5.00K0.00%00.0%Unchanged
Aspire Private Capital, LLC800$2.00K0.00%00.0%Unchanged
Kelly Financial Services LLC234$5620.00%−28−10.7%Reduced
Anchor Investment Management, LLC27$650.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec7$170.00%00.0%Unchanged
Morgan Stanley31$00.00%−2,495−98.8%Reduced
Bank of America Corp54$00.00%−1,680−96.9%Reduced
Tower Research Capital LLC (TRC)97$00.00%−1,064−91.6%Reduced
Huntington National Bank1$00.00%00.0%Unchanged
Wells Fargo & Company138$00.00%−1−0.7%Reduced
Royal Bank of Canada151$00.00%+53+54.1%Added
CWM, LLC1$00.00%00.0%Unchanged
TCI Wealth Advisors, Inc.3$00.00%00.0%Unchanged
UBS Group AG9$00.00%00.0%Unchanged
Carolina Wealth Advisors, LLC2$00.00%00.0%Unchanged
Citadel Advisors LLC0$00.00%−31,696−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−15,290−100.0%Sold out
Blue Bell Private Wealth Management, LLC0$00.00%−2−100.0%Sold out
Heritage Financial Services, LLC0$00.00%−67−100.0%Sold out